Unicycive Therapeutics, Inc.
UNCY
$5.09
$0.061.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.53M | 21.40M | 20.38M | 19.38M | 18.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.14M | 29.97M | 29.52M | 31.56M | 30.46M |
| Operating Income | -33.14M | -29.97M | -29.52M | -31.56M | -30.46M |
| Income Before Tax | -35.22M | -39.95M | -26.56M | -33.41M | -31.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.22 | -39.95 | -26.56 | -33.41 | -31.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.22M | -39.95M | -26.56M | -33.41M | -31.50M |
| EBIT | -33.14M | -29.97M | -29.52M | -31.56M | -30.46M |
| EBITDA | -33.11M | -29.93M | -29.48M | -31.52M | -30.44M |
| EPS Basic | -1.62 | -2.08 | -1.50 | -2.85 | -2.98 |
| Normalized Basic EPS | -1.01 | -1.30 | -0.93 | -1.78 | -1.86 |
| EPS Diluted | -1.62 | -2.08 | -2.04 | -3.39 | -3.52 |
| Normalized Diluted EPS | -1.01 | -1.30 | -0.93 | -1.78 | -1.86 |
| Average Basic Shares Outstanding | 90.32M | 75.71M | 63.48M | 52.62M | 43.45M |
| Average Diluted Shares Outstanding | 90.32M | 75.71M | 64.18M | 53.32M | 44.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.00% | 0.00% |